U.S. markets closed

Core Laboratories Inc. (CLB)

NYSE - NYSE Delayed Price. Currency in USD
14.95+0.83 (+5.88%)
At close: 04:00PM EST
14.95 0.00 (0.00%)
After hours: 05:45PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close14.12
Bid14.12 x 900
Ask15.40 x 1000
Day's Range14.19 - 15.02
52 Week Range13.82 - 27.95
Avg. Volume482,156
Market Cap697.633M
Beta (5Y Monthly)2.42
PE Ratio (TTM)29.31
EPS (TTM)0.51
Earnings DateJan 30, 2024 - Feb 05, 2024
Forward Dividend & Yield0.04 (0.28%)
Ex-Dividend DateFeb 09, 2024
1y Target Est19.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
71% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CLB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Core Laboratories Inc.
    CLB: Raising target price to $15.00CORE LABORATORIES INC has an Investment Rating of HOLD; a target price of $15.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Insider Monkey

    Core Laboratories (CLB) Fell Due to Weak US Land Drilling

    Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. US markets rallied strongly in Q4, with the S&P Index up 11.69%. However, Class A shares of the fund underperformed the Russell 2500 Growth Index. Healthcare and IT […]

  • Simply Wall St.

    Core Laboratories Inc. Just Missed Earnings - But Analysts Have Updated Their Models

    It's been a sad week for Core Laboratories Inc. ( NYSE:CLB ), who've watched their investment drop 12% to US$14.83 in...

  • Insider Monkey

    Core Laboratories N.V. (NYSE:CLB) Q4 2023 Earnings Call Transcript

    Core Laboratories N.V. (NYSE:CLB) Q4 2023 Earnings Call Transcript February 1, 2024 Core Laboratories N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the Core Laboratories Fourth Quarter 2023 Earnings Conference Call. All participants will […]